Paper27190010
Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.
Woodling NS and 19 others. Brain, 2016. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice. Papers, record 27190010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27190010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Gene Expression | Major topic |
| Hippocampus | Major topic |
| Memory Disorders | Major topic |
| Neuronal Plasticity | Major topic |
| Neurons | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Behavior, Animal | |
| Cyclooxygenase Inhibitors | |
| Disease Models, Animal | |
| Down-Regulation | |
| Electroencephalography | |
| Ibuprofen | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Rats | |
| Recognition, Psychology | |
| Tryptophan Oxygenase |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG030209 | NIA NIH HHS | United States | R01AG030209 | PubMed and NIH | NIH RePORTER |
| P30 NS069375 | NINDS NIH HHS | United States | P30NS069375 | PubMed and NIH | NIH RePORTER |
| F31 AG039195 | NIA NIH HHS | United States | F31AG039195 | PubMed and NIH | NIH RePORTER |
| R21 AG033914 | NIA NIH HHS | United States | R21AG033914 | PubMed and NIH | NIH RePORTER |
| N01 NS002331 | NINDS NIH HHS | United States | N01NS002331 | PubMed and NIH | NIH RePORTER |
| P50 AG047366 | NIA NIH HHS | United States | P50AG047366 | PubMed and NIH | NIH RePORTER |
| R21 AG042194 | NIA NIH HHS | United States | R21AG042194 | PubMed and NIH | NIH RePORTER |
| R01 AG048232 | NIA NIH HHS | United States | R01AG048232 | PubMed and NIH | NIH RePORTER |
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10908610 | Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. | J Neurosci | 2000 | https://conductscience.org/library/papers/10908610 | PubMed |
| 2 | 17573346 | Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17573346 | PubMed |
| 3 | 25792098 | Neuroinflammation in Alzheimer's disease. | Lancet Neurol | 2015 | https://conductscience.org/library/papers/25792098 | PubMed |
| 4 | 11337275 | Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. | Biomol Eng | 2001 | https://conductscience.org/library/papers/11337275 | PubMed |
| 5 | 17151600 | Genome-wide atlas of gene expression in the adult mouse brain. | Nature | 2007 | https://conductscience.org/library/papers/17151600 | PubMed |
| 6 | 19295151 | Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. | J Neurosci | 2009 | https://conductscience.org/library/papers/19295151 | PubMed |
| 7 | 21640374 | Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. | Cell | 2011 | https://conductscience.org/library/papers/21640374 | PubMed |
| 8 | 12925369 | Alzheimer disease in the US population: prevalence estimates using the 2000 census. | Arch Neurol | 2003 | https://conductscience.org/library/papers/12925369 | PubMed |
| 9 | 17785178 | Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. | Neuron | 2007 | https://conductscience.org/library/papers/17785178 | PubMed |
| 10 | 22016787 | Pumilio-2 function in the mouse nervous system. | PLoS One | 2011 | https://conductscience.org/library/papers/22016787 | PubMed |
| 11 | 21976023 | An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. | Nature | 2011 | https://conductscience.org/library/papers/21976023 | PubMed |
| 12 | 21705113 | The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease. | Neurobiol Aging | 2012 | https://conductscience.org/library/papers/21705113 | PubMed |
| 13 | 22915243 | Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. | Ann Neurol | 2012 | https://conductscience.org/library/papers/22915243 | PubMed |
| 14 | 20639188 | Kynurenine and its metabolites in Alzheimer's disease patients. | Adv Med Sci | 2010 | https://conductscience.org/library/papers/20639188 | PubMed |
| 15 | 16753269 | Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. | Neuroscience | 2006 | https://conductscience.org/library/papers/16753269 | PubMed |
| 16 | 8352945 | Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. | Neuron | 1993 | https://conductscience.org/library/papers/8352945 | PubMed |
| 17 | 16432513 | Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. | Nat Med | 2006 | https://conductscience.org/library/papers/16432513 | PubMed |
| 18 | 12891667 | Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. | Ann Neurol | 2003 | https://conductscience.org/library/papers/12891667 | PubMed |
| 19 | 15502089 | Simultaneous measurement of kynurenine and tryptophan in human plasma and supernatants of cultured human cells by HPLC with coulometric detection. | Clin Chem | 2004 | https://conductscience.org/library/papers/15502089 | PubMed |
| 20 | 18463254 | Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. | J Neurosci | 2008 | https://conductscience.org/library/papers/18463254 | PubMed |
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42277466 | Targeting the SIRT6-TDO2/KYNA-mTOR axis rescues synaptic and cognitive deficits in fetal growth restriction offspring. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/42277466 | PubMed |
| 41864895 | Nanomaterials for Alzheimer's disease: emerging strategies in diagnosis and therapy. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41864895 | PubMed |
| 41612418 | IDO family: the metabolic crossroads connecting immunity, nerves and tumors. | J Transl Med | 2026 | https://conductscience.org/library/papers/41612418 | PubMed |
| 41589495 | Enzymatic Biomarkers for Early Diagnosis of Alzheimer's Disease: Uncovering Key Targets and Mechanisms. | CNS Neurol Disord Drug Targets | 2026 | https://conductscience.org/library/papers/41589495 | PubMed |
| 41523281 | Anti-Neuroinflammation Activity of Essential Oils and Fatty Acids. | Food Sci Nutr | 2026 | https://conductscience.org/library/papers/41523281 | PubMed |
| 41495790 | Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer's disease-finding from Alzheimer's Disease Neuroimaging Initiative. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/41495790 | PubMed |
| 41416214 | Kynurenine Pathway Dysregulation in Parkinson's Disease: Insights for Disease Modulation and Therapy. | Int J Tryptophan Res | 2025 | https://conductscience.org/library/papers/41416214 | PubMed |
| 41216660 | Translatability of Animal Models for Alzheimer's Disease Using a Machine Learning Based Workflow. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/41216660 | PubMed |
| 41194875 | NeuproGemp, a polyphenol-rich botanical formula, ameliorates Alzheimer's-like pathology in APP/PS1 mice via inhibition of human glutaminyl cyclase. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41194875 | PubMed |
| 41016824 | Effects of Luffa cylindrica (L.) Roem Extract on Microglial Activation-Mediated Mild Cognitive Impairment via Regulation of CREB Signaling Pathway. | J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41016824 | PubMed |
| 40987460 | Effects of Long-Term Carprofen and Omeprazole Administration in C57BL/6J Mice. | J Am Assoc Lab Anim Sci | 2025 | https://conductscience.org/library/papers/40987460 | PubMed |
| 39519586 | Efficacy and Mechanism of Schisandra chinensis Fructus Water Extract in Alzheimer's Disease: Insights from Network Pharmacology and Validation in an Amyloid-β Infused Animal Model. | Nutrients | 2024 | https://conductscience.org/library/papers/39519586 | PubMed |
| 38612804 | Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612804 | PubMed |
| 38095013 | The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function. | Front Mol Neurosci | 2023 | https://conductscience.org/library/papers/38095013 | PubMed |
| 37671337 | In vitro studies on the pharmacological potential, anti-tumor, antimicrobial, and acetylcholinesterase inhibitory activity of marine-derived Bacillus velezensis AG6 exopolysaccharide. | RSC Adv | 2023 | https://conductscience.org/library/papers/37671337 | PubMed |
| 37638222 | Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors. | Saudi Pharm J | 2023 | https://conductscience.org/library/papers/37638222 | PubMed |
| 37488851 | Biomaterials-based anti-inflammatory treatment strategies for Alzheimer's disease. | Neural Regen Res | 2024 | https://conductscience.org/library/papers/37488851 | PubMed |
| 37314655 | Homocysteine May Decrease Glucose Uptake and Alter the Akt/GSK3β/GLUT1 Signaling Pathway in Hippocampal Slices: Neuroprotective Effects of Rivastigmine and Ibuprofen. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/37314655 | PubMed |
| 37300401 | Extension of life span by down-regulation of enzymes catalyzing tryptophan conversion into kynurenine: Possible implications for mechanisms of aging. | Exp Biol Med (Maywood) | 2023 | https://conductscience.org/library/papers/37300401 | PubMed |
| 37253984 | Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases. | Neurosci Bull | 2024 | https://conductscience.org/library/papers/37253984 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TDO2 | 6999 | PubTator's text mining | https://conductscience.org/library/genes/6999 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27190010
GET https://conductscience.org/api/papers/v1/27190010/references?page=2